Company Overview and News

Simon Extends Ties With Marriott, Aims UNTUCKit Store Opening

2018-05-18 zacks
Simon Property Group Inc. (SPG - Free Report) has been making concerted efforts to drive footfall at its properties. The company has been actively restructuring its portfolio and is aiming at premium acquisitions and transformative redevelopments. In sync with these efforts, Marriott International and Simon are planning to open five new hotels in the next several years at Simon’s shopping centers. This will be beneficial for both the companies as mixed-use properties are becoming a popular choice among hotel companies.

How To Retire Today With $1 Million

2018-05-18 seekingalpha
As the author of The REIT Forum, we focus on high yields with relatively low risk. Preferred shares are a safe way to raise your income compared to the common stock. I recently wrote a guide for preferred shares for investors.

7 Great Ways to Move Into Real Estate Investing

2018-05-18 investorplace
Real estate is an attractive investment category — and also a risky one. Owning physical real estate can provide attractive returns, but a lot can go wrong: tenants can leave in the middle of the night, pipes can burst and markets can change without warning.

Mall REITs: Narrative Vs. Reality

2018-05-18 seekingalpha
Malls continue to be the ugly of the REIT sector. The “death of the mall” narrative does jive with the reality of solid fundamentals and sales performance at top-tier malls.

Simon Unveils $4B Investment for Transformational Projects

2018-05-17 zacks
When store closures and retailer bankruptcies are creating a wreck for retail REITs, industry leader, Simon Property Group Inc. (SPG - Free Report) , surely knows how to turn around. The company has now launched a $4+ billion of investment plan to transform its properties aimed at creating value and drive footfall at its properties. Specifically, for Phipps Plaza in Buckhead (Atlanta), Georgia, its transformational efforts comprise inclusion of a boutique hotel and a restaurant from the luxury brand Nobu, a LifeTime wellness center, a Class-A office building and a dining experience.

Home Depot's Stock Falls As Sales Slip Amid Erratic Housing And Spending Data

2018-05-17 seekingalpha
Home Depot's Q1'18 earnings topped analysts’ estimates, but disappointed those who were looking for bigger net sales.

Macro Trumps Micro - Part I: Equity REITs That Even Fortune Tellers Hold

2018-05-17 seekingalpha
1. It was around mid-2016 when I turned bearish on many equity REITs (VNQ, IYR, RWR, ICF, SCHH, XLRE) At the time, most readers thought that I was wrong and I became known as one of SA's most anti-eREITs contributors.

SmartCentres Real Estate Investment Trust Announces Voting Results From Annual Meeting of Holders of Units and Special Voting Units

2018-05-16 globenewswire
TORONTO, May 16, 2018 (GLOBE NEWSWIRE) -- SmartCentres Real Estate Investment Trust (“SmartCentres” or the “REIT”) (TSX:SRU.UN) announced today the voting results from its Annual General Meeting of the Holders of Units and Special Voting Units (the “Meeting”) held today in Toronto, Ontario.

Home Depot's Stock Falls As Sales Slip Amid Erratic Housing And Spending Data

2018-05-16 seekingalpha
Home Depot's Q1'18 earnings topped analysts’ estimates, but disappointed those who were looking for bigger net sales.

Jane's April Dividend Income Tracker - Retirement Accounts

2018-05-15 seekingalpha
This is the second month I have officially tracked dividend income (in an article) for Jane's Traditional and Roth IRA Accounts. Her combined dividend income totaled $1,300.03.

Will Mall Traffic Blues Further Impact Simon Property Group?

2018-05-15 zacks
Retail REITs are not in the pink of health, as mall traffic continues to suffer due to the rapid shift in customers' shopping preferences, with e-retail taking precedence. In fact, with e-commerce gaining market share from the brick-and-mortar stores, retailers are compelled to reconsider their footprint and eventually opt for store closures, while others unable to cope with competition have been filing bankruptcies.

Dividend Growth Stocks For 2018

2018-05-15 seekingalpha
Instead of just focusing on high yields, investors should also be looking for investments with rapid dividend growth potential.

CEF RQI: Time To Get In

2018-05-15 seekingalpha
The last time I wrote a piece on RQI was on April 4th and I suggested to use patience before buying into this name.

Commodities Take Over Market Leadership

2018-05-11 seekingalpha
Commodity stocks have led since 2016, even over the vaunted FAANGS, though 2017 was a major hiccup.

4 of the Best REITs to Buy Now | InvestorPlace

2018-05-09 investorplace
Technological change and demographic shifts have seemingly touched every industry in one form or another. Real estate is no exception, and some of the best real estate investment trusts (REITs) to buy now touch upon these shifts. They have seen monumental shifts that have led to the ascendancy or decline in certain types of REITs.

Related Articles

TROV: TrovaGene Analysis and Research Report

13m - Asif

BUSINESS TrovaGene is a clinical-stage, precision medicine oncology therapeutics company. The company's primary focus is to develop oncology therapeutics for improved cancer care and to optimize drug development by leveraging its proprietary Precision Cancer Monitoring® (“PCM”) technology in tumor genomics. The company's lead drug candidate, PCM-075, is a Polo-like Kinase 1 (“PLK1”) selective adenosine triphosphate (“ATP”) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and synergy in combination with more than ten different chemotherapeutics and targeted therapies, such as Zytiga® (abiraterone acetate), Beleodaq® (belinostat), Quizartinib (AC220), a development stage FLT3 inhibitor, and Velcade® (bortezomib) in Acute Myeloid Leukemia (“AML”), metastatic Castration-Resistant Prostate Cancer (“mCRPC”) and other hematologic and solid tumor cancers. On March 15, 2017, the company announced the licensing of PCM-075, a PLK1 inhibitor...

SGMO: Sangamo BioSciences Analysis and Research Report

2018-05-19 - Asif

OVERVIEW Sangamo BioSciences is a clinical stage biotechnology company focused on translating ground-breaking science into genomic therapies that transform patients’ lives using its industry-leading platform technologies in genome editing, gene therapy, gene regulation and cell therapy. Sangamo BioSciences is a leader in the research and development of zinc finger proteins, or ZFPs, a naturally occurring class of proteins found in humans. Sangamo BioSciences has used its knowledge and expertise to develop a proprietary technology platform in both genome editing and gene regulation. ZFPs can be engineered to make zinc finger nucleases, or ZFNs, proteins that can be used to specifically modify DNA sequences by adding or knocking out specific genes, or genome editing, and ZFP transcription factors or ZFP TFs, proteins that can be used to increase or decrease gene expression, or gene regulation. In the process of developing this platform, Sangamo BioSciences has accrued signific...

HMNY: Helios and Matheson Analytics Analysis and Research Report

2018-05-19 - Asif

Business Overview The company provide high quality information technology, or IT, services and solutions including a range of technology platforms focusing on big data, business intelligence, and consumer-centric technology. More recently, to provide greater value to stockholders, the Company has sought to expand its business primarily through acquisitions that leverage its capabilities and expertise. As of March 31, 2018, the Company owned 81.2%, and as of the date of this report the Company owns 91.8%, of the outstanding shares of MoviePass (excluding outstanding MoviePass options and warrants). MoviePass is the premiere movie theater subscription service in the United States which provides its subscribers the ability to view up to one new movie title per day for one monthly subscription price. The company's more than 2 million subscribers have access to see films in over 91% of U.S movie theaters. By the end of April 2018, the company implemented certain measures ...

CUSIP: 828806109